Quoin Pharmaceuticals earnings were -$17.0M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest QNRX earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$5.0M, up 14.9% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, QNRX reported annual earnings of -$15.8M, with 76.3% growth. The next QNRX earnings date is Aug 6, 2026.
Quoin Pharmaceuticals Earnings Reports & History FAQ
What were Quoin Pharmaceuticals's earnings last quarter?
Quoin Pharmaceuticals (NASDAQ: QNRX) reported Q1 2026 earnings per share (EPS) of N/A, up N/A year over year. Total QNRX earnings for the quarter were -$5.00 million. In the same quarter last year, Quoin Pharmaceuticals's earnings per share (EPS) was N/A.
The next QNRX earnings call is Invalid Date. Add QNRX to your watchlist to be reminded of Quoin Pharmaceuticals's next earnings date.
Is Quoin Pharmaceuticals profitable or losing money?
As of the last Quoin Pharmaceuticals earnings report, Quoin Pharmaceuticals is currently losing money. Quoin Pharmaceuticals's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$16.99 million, a 62.63% increase year over year.
What was QNRX's earnings growth in the past year?
As of Quoin Pharmaceuticals's earnings date in Q2 2026, Quoin Pharmaceuticals's earnings has grown year over year. QNRX earnings in the past year totalled -$16.99 million.
What are Quoin Pharmaceuticals's earnings expectations?
The current EPS estimate for Quoin Pharmaceuticals's earnings report in Invalid Date is -$1.83.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.